Germany’s COPD market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX.X% during the forecast period.
According to estimates, in Germany, ten to twelve percent of adults older than 40 years suffer from COPD. While in 2010 6.8 million people suffered from COPD in Germany, it is estimated that this number will increase to 7.9 million by 2030. It is known that the primary cause for the development of COPD is tobacco smoke – the inhalation of heavily contaminated fine dust. In 90% of those affected by COPD, active smoking plays a role. However, it has been shown that also passive smoking can be a triggering factor as well as air pollution at the workplace caused by chemicals and dust. COPD is one of the most prevalent occupational diseases in Germany.
Increase in prevalence of COPD patients, increase in aging population, technological advancement in the treatment of COPD, increase in pipeline products growth, initiatives implemented by the government and non-government associations for rising in health awareness are the major factors that drive the market growth.